Valted Seq is a discovery stage biopharmaceutical company spearheaded by world-renowned scientists Dr. Ted Dawson and Dr. Valina Dawson of Johns Hopkins University. The company was founded on the belief that a deeper understanding of neurodegenerative pathways is essential to develop precision therapeutics and identify novel biomarkers for some of the most challenging neurodegenerative diseases, including Alzheimer’s and Parkinson’s. Valted Seq is part of the D&D Pharmatech/Neuraly family of companies, which works hand in hand with leading medical research institutions to advance groundbreaking healthcare innovations.


Biotechnology

Valted Seq

Mohammad N. Ranjbar

Quan Peng

Valted Seq's Leadership Team includes Joshua Yang and 11 others.

Leadership Team

About

Team members

Other teams at Valted Seq

Founding Team

Board of Directors